Cytori Therapeutics, Inc., (NASDAQ: CYTX) will present and provide an
audio webcast of its corporate presentation at the Fourth Annual Noble
Financial Equity Conference at 12:00 p.m. (Eastern Daylight Time) on
Monday, August 18, 2008 at the Loews Lake Las Vegas Resort, Nevada.
The audio webcast may be accessed under “Events
& Webcasts” in the Investor Relations
section of the Company's website at http://www.cytoritx.com.
The webcast will be available live and by replay one hour after the
presentation on the company’s website and
archived for 90 days.
About Cytori
Cytori’s (NASDAQ: CYTX) goal is to be the
global leader in regenerative medicine. The company is dedicated to
providing patients with new options for reconstructive surgery,
developing treatments for cardiovascular disease, and banking patients'
adult stem and regenerative cells. The Celution®
800 System is being introduced in Europe into the reconstructive surgery
market while the Celution® 900
System is being commercialized globally for cryopreserving a patient's
own stem and regenerative cells. Clinical trials are ongoing in
cardiovascular disease and planned for spinal disc degeneration,
gastrointestinal disorders, and other unmet medical needs. www.cytoritx.com
About Noble Financial
Noble Financial is a privately-held, full-service capital markets firm
driven by what is often overlooked by other firms - uncovering the value
embedded in the orphaned, undiscovered or misunderstood company. The
company focuses on converting market inefficiencies into profit
opportunities. Noble Financial supports emerging companies through
strategic advice, investment banking, market-making, sales & trading,
comprehensive equity research, and the development of institutional
support. Noble Financial’s equity conferences –
2008 marks their fourth annual - allow for a unique blend of
professional and personal interaction among a diverse cross-section of
executives. The company has operated for 24 years and has offices in
Florida, New York City and Boston.
Cautionary Statement Regarding Forward-Looking Statements
This press release includes forward-looking statements regarding events,
trends and business prospects, which may affect our future operating
results and financial position. Such statements are subject to risks and
uncertainties that could cause our actual results and financial position
to differ materially. Some of these risks and uncertainties include our
history of operating losses, the need for further financing, regulatory
uncertainties regarding the collection and results of, clinical data,
dependence on third party performance, and other risks and uncertainties
described under the "Risk Factors" in Cytori’s
Securities and Exchange Commission Filings. We assume no responsibility
to update or revise any forward-looking statements to reflect events,
trends or circumstances after the date they are made.
Media & Investor Contact:
Cytori Therapeutics
Tom
Baker, 858-875-5258
tbaker@cytoritx.com
